144 related articles for article (PubMed ID: 31862412)
1. Scaffold-hopping identifies furano[2,3-d]pyrimidine amides as potent Notum inhibitors.
Atkinson BN; Steadman D; Mahy W; Zhao Y; Sipthorp J; Bayle ED; Svensson F; Papageorgiou G; Jeganathan F; Frew S; Monaghan A; Bictash M; Jones EY; Fish PV
Bioorg Med Chem Lett; 2020 Feb; 30(3):126751. PubMed ID: 31862412
[TBL] [Abstract][Full Text] [Related]
2. 5-Phenyl-1,3,4-oxadiazol-2(3
Mahy W; Willis NJ; Zhao Y; Woodward HL; Svensson F; Sipthorp J; Vecchia L; Ruza RR; Hillier J; Kjær S; Frew S; Monaghan A; Bictash M; Salinas PC; Whiting P; Vincent JP; Jones EY; Fish PV
J Med Chem; 2020 Nov; 63(21):12942-12956. PubMed ID: 33124429
[TBL] [Abstract][Full Text] [Related]
3. An improved, scalable synthesis of Notum inhibitor LP-922056 using 1-chloro-1,2-benziodoxol-3-one as a superior electrophilic chlorinating agent.
Willis NJ; Bayle ED; Papageorgiou G; Steadman D; Atkinson BN; Mahy W; Fish PV
Beilstein J Org Chem; 2019; 15():2790-2797. PubMed ID: 31807213
[No Abstract] [Full Text] [Related]
4. Virtual Screening Directly Identifies New Fragment-Sized Inhibitors of Carboxylesterase Notum with Nanomolar Activity.
Steadman D; Atkinson BN; Zhao Y; Willis NJ; Frew S; Monaghan A; Patel C; Armstrong E; Costelloe K; Magno L; Bictash M; Jones EY; Fish PV; Svensson F
J Med Chem; 2022 Jan; 65(1):562-578. PubMed ID: 34939789
[TBL] [Abstract][Full Text] [Related]
5. Carboxylesterase Notum Is a Druggable Target to Modulate Wnt Signaling.
Bayle ED; Svensson F; Atkinson BN; Steadman D; Willis NJ; Woodward HL; Whiting P; Vincent JP; Fish PV
J Med Chem; 2021 Apr; 64(8):4289-4311. PubMed ID: 33783220
[TBL] [Abstract][Full Text] [Related]
6. Discovery of 2-phenoxyacetamides as inhibitors of the Wnt-depalmitoleating enzyme NOTUM from an X-ray fragment screen.
Atkinson BN; Steadman D; Zhao Y; Sipthorp J; Vecchia L; Ruza RR; Jeganathan F; Lines G; Frew S; Monaghan A; Kjær S; Bictash M; Jones EY; Fish PV
Medchemcomm; 2019 Aug; 10(8):1361-1369. PubMed ID: 31534655
[TBL] [Abstract][Full Text] [Related]
7. Discovery of N-(piperidin-3-yl)-N-(pyridin-2-yl)piperidine/piperazine-1-carboxamides as small molecule inhibitors of PCSK9.
Londregan AT; Aspnes G; Limberakis C; Loria PM; McClure KF; Petersen DN; Raymer B; Ruggeri RB; Wei L; Xiao J; Piotrowski DW
Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3685-3688. PubMed ID: 30482620
[TBL] [Abstract][Full Text] [Related]
8. Discovery of novel oxazepine and diazepine carboxamides as two new classes of heat shock protein 90 inhibitors.
Neubert T; Numa M; Ernst J; Clemens J; Krenitsky P; Liu M; Fleck B; Woody L; Zuccola H; Stamos D
Bioorg Med Chem Lett; 2015 Mar; 25(6):1338-42. PubMed ID: 25677667
[TBL] [Abstract][Full Text] [Related]
9. Design of a Potent, Selective, and Brain-Penetrant Inhibitor of Wnt-Deactivating Enzyme Notum by Optimization of a Crystallographic Fragment Hit.
Willis NJ; Mahy W; Sipthorp J; Zhao Y; Woodward HL; Atkinson BN; Bayle ED; Svensson F; Frew S; Jeganathan F; Monaghan A; Benvegnù S; Jolly S; Vecchia L; Ruza RR; Kjær S; Howell S; Snijders AP; Bictash M; Salinas PC; Vincent JP; Jones EY; Whiting P; Fish PV
J Med Chem; 2022 May; 65(10):7212-7230. PubMed ID: 35536179
[TBL] [Abstract][Full Text] [Related]
10. Discovery of imidazo[1,2-a]-, [1,2,4]triazolo[4,3-a]-, and [1,2,4]triazolo[1,5-a]pyridine-8-carboxamide negative allosteric modulators of metabotropic glutamate receptor subtype 5.
Felts AS; Rodriguez AL; Morrison RD; Bollinger KA; Venable DF; Blobaum AL; Byers FW; Thompson Gray A; Daniels JS; Niswender CM; Jones CK; Conn PJ; Lindsley CW; Emmitte KA
Bioorg Med Chem Lett; 2017 Nov; 27(21):4858-4866. PubMed ID: 28958625
[TBL] [Abstract][Full Text] [Related]
11. Screening of a Custom-Designed Acid Fragment Library Identifies 1-Phenylpyrroles and 1-Phenylpyrrolidines as Inhibitors of Notum Carboxylesterase Activity.
Mahy W; Patel M; Steadman D; Woodward HL; Atkinson BN; Svensson F; Willis NJ; Flint A; Papatheodorou D; Zhao Y; Vecchia L; Ruza RR; Hillier J; Frew S; Monaghan A; Costa A; Bictash M; Walter MW; Jones EY; Fish PV
J Med Chem; 2020 Sep; 63(17):9464-9483. PubMed ID: 32787107
[TBL] [Abstract][Full Text] [Related]
12. Lead optimization toward proof-of-concept tools for Huntington's disease within a 4-(1H-pyrazol-4-yl)pyrimidine class of pan-JNK inhibitors.
Wityak J; McGee KF; Conlon MP; Song RH; Duffy BC; Clayton B; Lynch M; Wang G; Freeman E; Haber J; Kitchen DB; Manning DD; Ismail J; Khmelnitsky Y; Michels P; Webster J; Irigoyen M; Luche M; Hultman M; Bai M; Kuok ID; Newell R; Lamers M; Leonard P; Yates D; Matthews K; Ongeri L; Clifton S; Mead T; Deupree S; Wheelan P; Lyons K; Wilson C; Kiselyov A; Toledo-Sherman L; Beconi M; Muñoz-Sanjuan I; Bard J; Dominguez C
J Med Chem; 2015 Apr; 58(7):2967-87. PubMed ID: 25760409
[TBL] [Abstract][Full Text] [Related]
13. Identification of nicotinamide phosphoribosyltransferase (NAMPT) inhibitors with no evidence of CYP3A4 time-dependent inhibition and improved aqueous solubility.
Zak M; Liederer BM; Sampath D; Yuen PW; Bair KW; Baumeister T; Buckmelter AJ; Clodfelter KH; Cheng E; Crocker L; Fu B; Han B; Li G; Ho YC; Lin J; Liu X; Ly J; O'Brien T; Reynolds DJ; Skelton N; Smith CC; Tay S; Wang W; Wang Z; Xiao Y; Zhang L; Zhao G; Zheng X; Dragovich PS
Bioorg Med Chem Lett; 2015 Feb; 25(3):529-41. PubMed ID: 25556090
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of cortical bone formation with thienopyrimidine based inhibitors of Notum Pectinacetylesterase.
Tarver JE; Pabba PK; Barbosa J; Han Q; Gardyan MW; Brommage R; Thompson AY; Schmidt JM; Wilson AGE; He W; Lombardo VK; Carson KG
Bioorg Med Chem Lett; 2016 Mar; 26(6):1525-1528. PubMed ID: 26897593
[TBL] [Abstract][Full Text] [Related]
15. Structural characterization of melatonin as an inhibitor of the Wnt deacylase Notum.
Zhao Y; Ren J; Hillier J; Jones M; Lu W; Jones EY
J Pineal Res; 2020 Mar; 68(2):e12630. PubMed ID: 31876313
[TBL] [Abstract][Full Text] [Related]
16. Notum palmitoleoyl-protein carboxylesterase regulates Fas cell surface death receptor-mediated apoptosis via the Wnt signaling pathway in colon adenocarcinoma.
Gong H; Niu Q; Zhou Y; Wang YX; Xu XF; Hou KZ
Bioengineered; 2021 Dec; 12(1):5241-5252. PubMed ID: 34402722
[TBL] [Abstract][Full Text] [Related]
17. Spirocyclic sulfamides as β-secretase 1 (BACE-1) inhibitors for the treatment of Alzheimer's disease: utilization of structure based drug design, WaterMap, and CNS penetration studies to identify centrally efficacious inhibitors.
Brodney MA; Barreiro G; Ogilvie K; Hajos-Korcsok E; Murray J; Vajdos F; Ambroise C; Christoffersen C; Fisher K; Lanyon L; Liu J; Nolan CE; Withka JM; Borzilleri KA; Efremov I; Oborski CE; Varghese A; O'Neill BT
J Med Chem; 2012 Nov; 55(21):9224-39. PubMed ID: 22984865
[TBL] [Abstract][Full Text] [Related]
18. Discovery of Novel Central Nervous System Penetrant Metabotropic Glutamate Receptor Subtype 2 (mGlu
Childress ES; Wieting JM; Felts AS; Breiner MM; Long MF; Luscombe VB; Rodriguez AL; Cho HP; Blobaum AL; Niswender CM; Emmitte KA; Conn PJ; Lindsley CW
J Med Chem; 2019 Jan; 62(1):378-384. PubMed ID: 30350962
[TBL] [Abstract][Full Text] [Related]
19. Designed switch from covalent to non-covalent inhibitors of carboxylesterase Notum activity.
Atkinson BN; Willis NJ; Zhao Y; Patel C; Frew S; Costelloe K; Magno L; Svensson F; Jones EY; Fish PV
Eur J Med Chem; 2023 May; 251():115132. PubMed ID: 36934521
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and optimization of bis-amide derivatives as CSF1R inhibitors.
Ramachandran SA; Jadhavar PS; Miglani SK; Singh MP; Kalane DP; Agarwal AK; Sathe BD; Mukherjee K; Gupta A; Haldar S; Raja M; Singh S; Pham SM; Chakravarty S; Quinn K; Belmar S; Alfaro IE; Higgs C; Bernales S; Herrera FJ; Rai R
Bioorg Med Chem Lett; 2017 May; 27(10):2153-2160. PubMed ID: 28377059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
